首页> 外文期刊>The Journal of arthroplasty >Long-term survivorship analysis of the cementless Spotorno femoral component in patients less than 50 years of age.
【24h】

Long-term survivorship analysis of the cementless Spotorno femoral component in patients less than 50 years of age.

机译:小于50岁患者的非骨水泥性Spotorno股骨组件的长期生存分析。

获取原文
获取原文并翻译 | 示例
           

摘要

The long-term survival of the cementless Spotorno (CLS) femoral component (Zimmer Inc, Warsaw, USA) was evaluated in a consecutive series of 85 patients (100 hips) less than 50 years of age. The mean follow-up was 12.3 years. Two patients (3 hips) were lost to follow-up, and 3 (4 hips) died. The survival rate of the CLS stem was 96.9% (confidence interval [CI], 93.6%-100%) after 13 years based on revision of the stem for any reason. The survival of the stem with revision for aseptic loosening as the end point was 97.9% (CI, 95.1%-100%) at 13 years. The mean Harris hip score at time of follow-up was 94. The long-term survival of the CLS stem is excellent in patients less than 50 years of age.
机译:非骨水泥型Spotorno(CLS)股骨组件(Zimmer Inc,Warsaw,USA)的连续生存期在连续的一系列年龄小于50岁的85例患者(100髋)中进行了评估。平均随访时间为12。3年。两名患者(3髋)失去随访,3例(4髋)死亡。基于任何原因修订后的13年,CLS茎的存活率为96.9%(置信区间[CI],93.6%-100%)。 13年时,以无菌性松动翻修为终点的茎的存活率为97.9%(CI,95.1%-100%)。随访时哈里斯的平均髋关节评分为94。CLS茎的长期存活率在50岁以下的患者中极佳。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号